From MarketBeat LLC:

Railway Pension Investments Ltd reduced its shares in Pfizer Inc. by 43% in the third quarter. They sold 959,392 shares and now own 1,269,400, valued at $42,106,000.

Several institutional investors, including Worth Asset Management, Hibernia Wealth Partners, and others have made purchases or established positions in Pfizer stock. Hedge funds and institutional investors own 68.05% of the company’s stock.

Director Scott Gottlieb purchased 3,000 shares of Pfizer stock. After the purchase, he now owns 9,000 shares valued at approximately $238,230.

Thirteen investment analysts have rated Pfizer’s stock as hold, while five have given it a buy rating, with a consensus target price of $39.89.

Pfizer Inc. opened at $29.47 on Friday. The company reported a quarterly dividend increase from $0.41 to $0.42 per share, the new rate beginning on Friday, March 1st.

Pfizer focuses on various therapeutic areas including cardiovascular metabolic, migraine, and women’s health. The company also plays a role in infectious diseases, COVID-19 prevention and treatment, and potential future mRNA and antiviral products.

Pfizer Inc. last issued its quarterly earnings data on Tuesday, October 31st. The biopharmaceutical company reported ($0.17) earnings per share for the quarter and had a return on equity of 16.72%.

MarketBeat keeps track of Wall Street’s top-rated and best-performing research analysts. When considering investing in Pfizer Inc., it may be beneficial to explore other investment opportunities.



Read more: Railway Pension Investments Ltd Lowers Stake in Pfizer Inc. (NYSE:PFE)